13G Filing: Visium Asset Management and Sage Therapeutics, Inc. (SAGE)

---

CUSIP No. 78667J108		Page 5 of 11 Pages

Item 1(a)

Name of Issuer:

Sage Therapeutics, Inc.

(b)

Address of Issuers Principal Executive Offices:

215 First Street

Cambridge, MA 02142

Item 2

(1)  (3) This statement is filed on behalf of the following:

(1)

Visium Asset Management, LP, a Delaware limited partnership (VAM), with its principal business office c/o Visium Asset Management, LP, 888 Seventh Avenue, New York, NY 10019.

(2)

JG Asset, LLC, a Delaware limited liability company (JG Asset), with its principal business office c/o Visium Asset Management, LP, 888 Seventh Avenue, New York, NY 10019. JG Asset is the General Partner of VAM.

(3)

Jacob Gottlieb (Gottlieb), a natural person, with his principal business office c/o Visium Asset Management, LP, 888 Seventh Avenue, New York, NY 10019. Gottlieb is the Managing Member of JG Asset.

(d)

Title of Class of Securities:

Common Stock, $0.0001 par value per share

(e)

CUSIP Number:

78667J108

Page 5 of 11 Pages